preclinical biotech

CAMBRIDGE, Mass. & HOUSTON, Feb. 5, 2026 — Decoy Therapeutics, Inc., a preclinical-stage biotechnology company developing next-generation peptide conjugate...

LEHI, Utah — December 23, 2025 — CancerVax, a pre-clinical biopharmaceutical innovator, has released a year-end scientific and strategic...